These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Olfactory mucosa and Alzheimer's disease. Technique for biopsy and ultrastructural study]. Laccourreye L, Brouillard M, Emile J, Pouplard-Barthelaix A. Ann Otolaryngol Chir Cervicofac; 1991; 108(5):277-85. PubMed ID: 1759743 [Abstract] [Full Text] [Related]
3. [Ultrastructural and immunohistochemical study of the olfactory mucosa in Alzheimer's disease]. Brouillard M, Laccourreye L, Jabbour W, Emile J, Pouplard-Barthelaix A. Bull Assoc Anat (Nancy); 1994 Mar; 78(240):25-8. PubMed ID: 8054692 [Abstract] [Full Text] [Related]
4. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease. Gómez-Ramos P, Morán MA. Microsc Res Tech; 1998 Oct 01; 43(1):49-58. PubMed ID: 9829459 [Abstract] [Full Text] [Related]
5. [Definitive diagnosis of Alzheimer's disease using olfactory mucosal biopsy]. Yamagishi M, Ishizuka Y, Seki K. Nihon Jibiinkoka Gakkai Kaiho; 1994 Jan 01; 97(1):51-60. PubMed ID: 8176537 [Abstract] [Full Text] [Related]
6. Design, synthesis and biological evaluation of trimethine cyanine dyes as fluorescent probes for the detection of tau fibrils in Alzheimer's disease brain and olfactory epithelium. Gu J, Anumala UR, Heyny-von Haußen R, Hölzer J, Goetschy-Meyer V, Mall G, Hilger I, Czech C, Schmidt B. ChemMedChem; 2013 Jun 01; 8(6):891-7. PubMed ID: 23592568 [Abstract] [Full Text] [Related]
7. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Duda JE, Shah U, Arnold SE, Lee VM, Trojanowski JQ. Exp Neurol; 1999 Dec 01; 160(2):515-22. PubMed ID: 10619569 [Abstract] [Full Text] [Related]
9. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Swerdlow RH. Neurobiol Aging; 2007 Oct 01; 28(10):1465-80. PubMed ID: 16876913 [Abstract] [Full Text] [Related]
10. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Lüth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, Arendt T, Münch G. Cereb Cortex; 2005 Feb 01; 15(2):211-20. PubMed ID: 15238435 [Abstract] [Full Text] [Related]
11. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM. Am J Pathol; 1993 Aug 01; 143(2):565-78. PubMed ID: 8342603 [Abstract] [Full Text] [Related]
12. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I, Barrachina M, Puig B. Acta Neuropathol; 2002 Dec 01; 104(6):583-91. PubMed ID: 12410379 [Abstract] [Full Text] [Related]
14. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM. Neurobiol Aging; 2007 Mar 01; 28(3):327-35. PubMed ID: 16574280 [Abstract] [Full Text] [Related]